We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACRE
2876
Ares Commercial Real Estate
ACRE
$236M
$1.07M ﹤0.01%
70,165
+16,850
+32% +$257K
HEDJ icon
2877
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.86B
$1.07M ﹤0.01%
31,724
+5,176
+19% +$170K
OSB
2878
DELISTED
Norbord Inc.
OSB
$1.07M ﹤0.01%
44,551
-9,242
-17% -$217K
TECK icon
2879
CALL
Teck Resources
TECK
$29.5B
$1.07M ﹤0.01%
+65,700
New +$1.24M
ANH
2880
DELISTED
Anworth Mortgage Asset Corporation
ANH
$1.06M ﹤0.01%
321,716
+68,308
+27% +$244K
MEI icon
2881
Methode Electronics
MEI
$499M
$1.06M ﹤0.01%
31,513
-2,285
-7% -$69.2K
TK icon
2882
PUT
Teekay
TK
$1.03B
$1.06M ﹤0.01%
265,300
REGI
2883
DELISTED
Renewable Energy Group, Inc.
REGI
$1.06M ﹤0.01%
70,574
+373
+0.5% +$5.15K
HFWA icon
2884
Heritage Financial
HFWA
$1.23B
$1.06M ﹤0.01%
39,218
+5,580
+17% +$154K
CBPO
2885
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$1.06M ﹤0.01%
9,223
-28,138
-75% -$2.8M
INOV
2886
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$1.05M ﹤0.01%
64,317
+8,569
+15% +$137K
ENB icon
2887
CALL
Enbridge
ENB
$118B
$1.05M ﹤0.01%
+30,000
New +$1.04M
ALDR
2888
DELISTED
Alder Biopharmaceuticals
ALDR
$1.05M ﹤0.01%
55,652
-102,616
-65% -$1.17M
RARX
2889
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.05M ﹤0.01%
44,386
+8,293
+23% +$246K
FNKO icon
2890
Funko
FNKO
$323M
$1.05M ﹤0.01%
50,875
+41,679
+453% +$964K
TPCO
2891
DELISTED
Tribune Publishing Company Common Stock
TPCO
$1.05M ﹤0.01%
121,878
-1,336
-1% -$10.7K
JRVR icon
2892
James River Group Holdings
JRVR
$213M
$1.04M ﹤0.01%
20,339
-116
-0.6% -$5.66K
DHR icon
2893
PUT
Danaher
DHR
$139B
$1.04M ﹤0.01%
+8,122
New +$1.02M
BKD icon
2894
Brookdale Senior Living
BKD
$3.43B
$1.04M ﹤0.01%
137,029
+38,879
+40% +$308K
PIPR icon
2895
Piper Sandler
PIPR
$5.13B
$1.04M ﹤0.01%
55,036
+12,640
+30% +$236K
BBT
2896
Beacon Financial Corp
BBT
$2.69B
$1.04M ﹤0.01%
35,402
-5,328
-13% -$162K
MYE icon
2897
Myers Industries
MYE
$1.38B
$1.04M ﹤0.01%
58,672
+5,708
+11% +$97.5K
PFX icon
2898
PhenixFIN
PFX
$1.04M ﹤0.01%
+20,000
New +$1.03M
EGOV
2899
DELISTED
NIC Inc
EGOV
$1.03M ﹤0.01%
50,053
+1,800
+4% +$35.2K
BTE icon
2900
Baytex Energy
BTE
$3.12B
$1.03M ﹤0.01%
698,176
+451,494
+183% +$647K

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.